HIV / AIDS in the News

Legendary actor makes eye-opening HIV claim - PennLive.com

 

Press Release: Bipartisan Florida Lawmakers Advocate for Updates to Ryan White HIV/AIDS Program Funding - Quiver Quantitative

 

Bipartisan Florida Delegation Urges Implementation of Proposal to Strengthen HIV/AIDS Care - U.S. Representative Lois Frankel (.gov)

 

Federally funded clinical trial suggests knowing HIV ‘viral load’ doesn’t improve number of patients seeking needed care - EurekAlert!

 

Washington HIV accused 'first to mind' after diagnosis, court hears - BBC

 

Washington HIV accused 'first to mind' after diagnosis, court hears - BBC

 

HIV in 2025 Defined by Challenges Throughout the Year, Despite Some Advances - The American Journal of Managed Care® (AJMC®)

 

STREAMS project is transforming treatment access for Uganda’s HIV-positive youth - Ladue News

 

Gilead's single-tablet HIV combo of bictegravir, lenacapavir passes another late-stage test on way to filings - Fierce Pharma

 

Innovative high-level leadership to strengthen and sustain the HIV response in Uganda - UNAIDS

 

GILD's Bictegravir and Lenacapavir Regimen for HIV Meets Primary Goal - Zacks Investment Research

 

AIDS Alabama Highlights HIV Care and Community in Birmingham - GLAAD

 

Nalchik nurse sentenced to prison over accidental HIV, hepatitis infection of patients - OC Media

 

Achieving lasting remission for HIV - KTVZ

 

Gilead’s Investigational Single-Tablet Regimen of Bictegravir and Lenacapavir for HIV Treatment Meets Primary Endpoint in Phase 3 ARTISTRY-2 Trial - BioSpace

 

Gilead's experimental HIV treatment non-inferior to blockbuster drug in trial - Reuters

 

Clinical trial suggests knowing HIV 'viral load' doesn't improve number of patients seeking needed care - European AIDS Treatment Group

 

A key to long-term HIV control - National Institutes of Health (NIH) | (.gov)

 

Gilead’s HIV treatment meets primary trial endpoint - Pharmafile

 

Gilead’s experimental HIV treatment meets main goal in late-stage trial - WKZO

 

The Tri-Pharma Tournament: Gilead, ViiV, and MSD Battle for the HIV Drug Cup - geneonline.com

 

Canada's reduced Global Fund pledge threatens health at home and abroad - News-Medical

 

Researchers See Dramatic Drop in HIV-Infected Immune Cells in Patient After Cancer Treatment Received | Newswise - Newswise

 

Higher education increased HIV risk in Africa then became protective - European AIDS Treatment Group

 

Vitamin D and calcium supplements help improve bone density of adolescents with HIV - European AIDS Treatment Group

 

HIV Infections Surge Among Older Adults in China, With Zhejiang Accounting for 40% - Vision Times

 

Population-level data reveal widespread HIV drug resistance in sub-Saharan Africa - European AIDS Treatment Group

 

Researchers see dramatic drop in HIV-infected immune cells in patient after cancer treatment received - European AIDS Treatment Group

 

Gilead’s experimental HIV treatment meets main goal in late-stage trial - WTVB

 

Gilead’s investigational single-tablet regimen of bictegravir and lenacapavir for HIV treatment meets primary endpoint in Phase 3 ARTISTRY-2 trial - European AIDS Treatment Group